PR Newswire

WEST CHESTER, Pa., June 3, 2024 /PRNewswire-PRWeb/ — Track Rabbit, the marketing-based event registration, member management, and administrative e-commerce platform…

The Data Intelligence for All-themed event will feature keynotes from co-founders Ali Ghodsi, Matei Zaharia, Patrick Wendell, and Reynold Xin…

DANA POINT, Calif., June 3, 2024 /PRNewswire/ — Today at Home Care 100, CareConnect, LLC, a leader in home care…

Architectural Firm Celebrates Decade of Gold Nugget Design Awards Images available here. SANTA ANA, Calif., June 3, 2024 /PRNewswire/ —…

HONG KONG, June 3, 2024 /PRNewswire/ — Buzbug, a pioneering force in innovative insect control technologies, is thrilled to announce the…

Combined entity creates unmatched offering for content creators, publishers and distributors TEL-AVIV, Israel, June 3, 2024 /PRNewswire/ — In a strategic…

SAN FRANCISCO, June 3, 2024 /PRNewswire/ — OpenBench, Inc., a pioneer in AI enabled success-driven small molecule discovery partnerships, today…

FREMONT, Calif., June 3, 2024 /PRNewswire/ — In recent years, autonomous driving has made remarkable advancements. However, many autonomous driving…

— Leading Provider of Power Solutions Solidifies Market Leadership with Lithium-ion Battery that Delivers Extended Run Times, Advanced Safety, and…

Santé Center for Healing has been approved by The Joint Commission as a JCAHO accredited facility. Santé earned The Joint…

Pilot in select stores offers customers a chance to bring their dream kitchen to life with Lowe’s Style Studio™ CHARLOTTE, N.C.,…

NORCROSS, Ga., June 3, 2024 /PRNewswire/ — Hi-Tech Pharmaceuticals has increased its capacity on Precision Protein™, which is arguably the…

NEW YORK and MEXICO CITY, June 3, 2024 /PRNewswire/ — Bloomberg SEF LLC today announced that the first electronically traded…

TAIPEI, June 3, 2024 /PRNewswire/ — Doing a keynote before the Computex starts and during the evening at Taiwan’s top…

–       Long-term efficacy data from the registrational Phase 2 trial of REZLIDHIA® (olutasidenib) in heavily pretreated patients with R/R mIDH1 AML,…